Literature DB >> 25677307

Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature.

Sven Gläser1, Stefan Krüger, Martin Merkel, Peter Bramlage, Felix J F Herth.   

Abstract

The objective of this systematic review was to discuss our current understanding of the complex relationship between chronic obstructive pulmonary disease (COPD) and type-2 diabetes mellitus (T2DM). We performed a systematic search of the literature related to both COPD and diabetes using PubMed. Relevant data connecting both diseases were compiled and discussed. Recent evidence suggests that diabetes can worsen the progression and prognosis of COPD; this may result from the direct effects of hyperglycemia on lung physiology, inflammation or susceptibility to bacterial infection. Conversely, it has also been suggested that COPD increases the risk of developing T2DM as a consequence of inflammatory processes and/or therapeutic side effects related to the use of high-dose corticosteroids. In conclusion, although there is evidence to support a connection between COPD and diabetes, additional research is needed to better understand these relationships and their possible implications.

Entities:  

Mesh:

Year:  2015        PMID: 25677307     DOI: 10.1159/000369863

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  39 in total

1.  Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis.

Authors:  Tito Borner; Jayme L Workinger; Ian C Tinsley; Samantha M Fortin; Lauren M Stein; Oleg G Chepurny; George G Holz; Aleksandra J Wierzba; Dorota Gryko; Ebba Nexø; Evan D Shaulson; Ankur Bamezai; Valentina A Rodriguez Da Silva; Bart C De Jonghe; Matthew R Hayes; Robert P Doyle
Journal:  Cell Rep       Date:  2020-06-16       Impact factor: 9.423

Review 2.  Physiopathological relationship between chronic obstructive pulmonary disease and insulin resistance.

Authors:  Felipe Vilaça Cavallari Machado; Fabio Pitta; Nidia Aparecida Hernandes; Gisele Lopes Bertolini
Journal:  Endocrine       Date:  2018-03-06       Impact factor: 3.633

3.  Disparities in diabetes-related multiple chronic conditions and mortality: The influence of race.

Authors:  John M Clements; Brady T West; Zachary Yaker; Breanna Lauinger; Deven McCullers; James Haubert; Mohammad Ali Tahboub; Gregory J Everett
Journal:  Diabetes Res Clin Pract       Date:  2019-12-15       Impact factor: 5.602

4.  Multiple Chronic Conditions in Spousal Caregivers of Older Adults With Functional Disability: Associations With Caregiving Difficulties and Gains.

Authors:  Courtney A Polenick; Amanda N Leggett; Noah J Webster; Benjamin H Han; Steven H Zarit; John D Piette
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-01-01       Impact factor: 4.077

Review 5.  Noninvasive glucose detection in exhaled breath condensate.

Authors:  Divya Tankasala; Jacqueline C Linnes
Journal:  Transl Res       Date:  2019-05-30       Impact factor: 7.012

6.  Air pollution and respiratory health among diabetic and non-diabetic subjects in Pune, India-results from the Wellcome Trust Genetic Study.

Authors:  Morteza Abdullatif Khafaie; Sundeep Santosh Salvi; Chittaranjan Sakerlal Yajnik; Ajay Ojha; Behzad Khafaie; Sharad Damodar Gore
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-17       Impact factor: 4.223

7.  [Neutrophil to lymphocyte ratio as a predictor for type 2 diabetes mellitus in patients with chronic obstructive pulmonary disease: a cohort study of 404 cases].

Authors:  Tao Ye; Yin Yang; Kai Wang; Mei Wang; Jia Sun; Yue DU; Xin Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-10-20

8.  Type 2 Diabetes and Chronic Conditions Disparities in Medicare Beneficiaries in the State of Michigan.

Authors:  John M Clements; Mariana Rosca; Carla Cavallin; Shelby Falkenhagen; Thomas Ittoop; Christina K Jung; Megan Mazzella; Joseph A Reed; Megan Schluentz; Caleb VanDyke
Journal:  Am J Med Sci       Date:  2020-01-23       Impact factor: 2.378

9.  A second-generation glucagon-like peptide-1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian models.

Authors:  Tito Borner; Evan D Shaulson; Ian C Tinsley; Lauren M Stein; Charles C Horn; Matthew R Hayes; Robert P Doyle; Bart C De Jonghe
Journal:  Diabetes Obes Metab       Date:  2020-06-25       Impact factor: 6.577

10.  [The role of counterinsular hormones in the regulation of glucose homeostasis and the pathogenesis of type 2 diabetes mellitus in COPD].

Authors:  V I Kobylyansky
Journal:  Probl Endokrinol (Mosk)       Date:  2021-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.